Kraig Biocraft Laboratories, Inc.

KBLB·OTC Markets OTCQB·Basic Materials
Compare
0.0825+0.0005 (+0.61%)today
As of Nov 4, 10:25 AM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0820
Open0.0879
Day range0.08250.0879
52-week range0.07000.1600
Off day high−6.14%
Off 52-week high−48.44%
Volume1.10K
Avg. volume (3M)915.03K
Market cap92.02M
EPS (TTM)0.000000
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.71
Shares outstanding1.12B
Short interest—
Earnings dateAug 12, 2025 (est.)
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
KBLB BGLC ITECH.ST KUY.F 004545.KS KEQU
Market cap 92.02M 2.49M 716.27M 3.28B — 98.44M
P/E (TTM) — — 14.2 72.7 — 12.3
Forward P/E — — 15.3 — — 15.7
Price/book -7.5 0.3 3.5 0.8 — 1.3
Dividend yield — — 1.95% 2.94% — —
1-year change −11.11% −81.99% −5.18% +11.83% −73.00% −15.34%
Today +0.61% −9.56% −6.86% +4.81% +30.00% −0.67%

The closest companies by business and industry (Specialty Chemicals). Prices may be delayed up to 20 min.

Latest news

All KBLB news ›
The Manila Times··2 outletsPositive

Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth

Prodigy Silk is Kraig Labs' production arm, a vertically integrated operation that rears, harvests, and processes recombinant spider silk. The additional capital will support new capacity, strengthen infrastructure, and push spider silk…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

14mentions in 30 days
12with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance